Convergence and divergence of the signaling pathways for insulin and phosphoinositolglycans

Molecular Medicine

Volumn 4, Issue 5, 1998, Pages 299-323

  Müller, Günter ^a   Wied, Susanne ^a   Piossek, Christine ^a   Bauer, Andrea ^a   Bauer, Jochen ^a   Frick, Wendelin ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLIMEPIRIDE; GLUCOSE; GLYCAN DERIVATIVE; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE; INOSITOL PHOSPHATE; INSULIN; MEMBRANE PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; VANADATE SODIUM;

ADIPOCYTE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; DIAPHRAGM; ENZYME ACTIVITY; GLUCOSE TRANSPORT; HEART MUSCLE CELL; LIPOGENESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION;

EID: 0031877822     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401738     Document Type: Article

References (97)

1. Kahn CR. (1994) Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43: 1066-1084.
2. White MF, Kahn CR. (1994) The insulin signaling system. J. Biol. Chem. 269: 1-4.
3. Saltiel AR. (1996) Diverse signaling pathways in the cellular actions of insulin. Am. J. Physiol. 270: 375-385.
4. White MF. (1997) The insulin signalling system and the IRS proteins. Diabetologia 40: S12-S17.
5. Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J, Kahn CR. (1994) Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 14: 4902-4911.
6. Okada T, Kawano Y, Sakakibara T, Hazeki O, Ui M. (1994) Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. J. Biol. Chem. 269: 3568-3573.
7. Liscovitch M, Cantley LC. (1995) Signal transduction and membrane traffic: The PITP/phosphoinositide connection. Cell 81: 659-662.
8. Myers MG, Wang LM, Sun X. (1994) The role of IRS-1/GRB2 complexes in insulin signaling. Mol. Cell. Biol. 14: 3577-3587.
9. Myers MG, While MF. (1995) New frontiers in insulin receptor substrate signaling. Trends Endocrinol. Metab. 6: 209-215.
10. Häring HU. (1991) The insulin receptor: Signalling mechanism and contribution to the pathogenesis of insulin resistance. Diabetologia 34: 848-861.
11. Quon MJ, Butte AJ, Taylor SI. (1994) Insulin signal transduction pathways. Trends Endocrinol. Metab. 5: 369-376.
12. Saltiel AR. (1990) Second messengers of insulin action. Diabetes Care 13: 244-256.
13. Varela-Nieto I, Leon Y, Caro HN. (1996) Cell signalling by inositol phosphoglycans from different species. Comp. Biochem. Physiol. 115B: 223-241.
14. Romero G, Larner J. (1993) Insulin mediators and the mechanism of insulin action. Adv. Pharmacol. 24: 21-50.
15. Jarett L, Kiechle FL, Macaulay SL, Parker JC, Kelly KL. (1985) Intracellular mediators of insulin action. In: Cech MP (ed). Molecular Basis of Insulin Action. Plenum Publishing, New York, pp. 171-182.
16. Saltiel AR, Fox JA, Sherline P, Cuatrecasas P. (1986) Insulin stimulates the generation from hepatic plasma membranes of modulators derived from an inositol glycolipid. Science 233: 967-972.
17. Mato JM, Kelly KL, Abler A, Jarett L. (1987) Partial structure of an insulin-sensitive glycophospholipid. J. Biol. Chem. 262: 2131-2137.
18. Mato JM, Kelly KL, Abler A, Jarett L, Corkey BE, Cashel JA, Zopf D. (1987) Partial structure of an insulin-sensitive glycophospholipid. Biochem. Biophys. Res. Commun. 146: 764-770.
19. Low MG, Saltiel AR. (1988) Structural and functional roles of glycosyl-phosphatidylinositol in membranes. Science 239: 268-275.
20. Cross GAM. (1990) Glycolipid anchoring of plasma membrane proteins. Annu. Rev. Cell Biol. 6: 1-39.
21. McConville MJ, Ferguson MAJ. (1993) The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes. Biochem. J. 294: 305-324.
22. Nosjean O, Briolay A, Roux B. (1997) Mammalian GPI proteins: sorting, membrane residence and functions. Biochim. Biophys. Acta 1331: 153-186.
23. Müller G, Schubert K, Fiedler F, Bandlow W. (1992) The cAMP-binding ectoprotein from Saccharomyces cerevisiae is membrane-anchored by glycosyl-phosphatidylinositol. J. Biol. Chem. 267: 25337-25346.
24. Müller G, Wied S, Crecelius A, Kessler A, Eckel J. (1997) Phosphatidylinositolglycan-peptides from yeast potently induce metabolic insulin actions in isolated rat adipocytes, cardiomyocytes, and diaphragms. Endocrinology 138: 3459-3475.
25. Müller G, Dearey E-A, Pünter J. (1993) The sulfonylurea drug, glimepiride, stimulates release of glycosylphosphatidylinositol-anchored plasma membrane proteins from 3T3 adipocytes. Biochem. J. 289: 509-521.
26. Müller G, Dearey E-A, Korndörfer A, Bandlow W. (1994) Stimulation of a glycosyl phosphatidylinositol-specific phospholipase by insulin and the sulfonylurea, glimepiride, in rat adipocytes depends on increased glucose transport. J. Cell Biol. 126: 1267-1276.
27. Müller G, Wetekam E-M, Wied S, Bandlow W. (1994) Membrane association of lipoprotein lipase and a cAMP-binding ectoprotein in rat adipocytes. Biochemistry 33: 12149-12159.
28. Kahn BB. (1995) Lilly Lecture: Glucose transport: pivotal step in insulin action. Diabetes 45: 1644-1654.
29. Romero GL, Gamez G, Huang LC, Lilley K, Luttrell L. (1990) Anti-inositolglycan antibodies selectively block some of the actions of insulin in intact BC3H1 cells. Proc. Natl. Acad. Sci. U.S.A. 87: 1476-1480.
30. Lazar DF, Knez JJ, Medof ME, Cuatrecasas P, Saltiel AR. (1994) The stimulation of glycogen synthesis by insulin in human erythroleukemia cells requires the synthesis of glycosyl-phosphatidylinositol. Proc. Natl. Acad. Sci. U.S.A. 91: 9665-9669.
31. Fonteles MC, Huang LC, Larner J. (1996) Infusion of pH 2.0 D-chiro-inositol glycan insulin putative mediator normalizes plasma glucose in streptozotocin diabetic rats at a dose equivalent to insulin without inducing hypoglycemia. Diabetologia 39: 731-734.
32. Asplin I, Galasko G, Larner J. (1993) Chiro-inositol deficiency and insulin resistance: A comparison of the chiro-inositol- and myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects. Proc. Natl. Acad. Sci. U.S.A. 90: 5924-5928.
33. Shashkin PN, Shashkina EF, Fernqvist-Forbes E, Zhou Y-P, Grill V, Katz A. (1997) Insulin mediators in man: Effects of glucose ingestion and insulin resistance. Diabetologia 40: 557-563.
34. Saltiel AR, Cuatrecasas P. (1986) Insulin stimulates the generation from hepatic plasma membranes of modulators derived from an inositol glycolipid. Proc. Natl. Acad. U.S.A. 83: 5793-5797.
35. Kelly KL, Merida I, Wong EHA, DiCenzo D, Mato JM. (1987) A phospho-oligosaccharide mimics the effect of insulin to inhibit isoproterenol-dependent phosphorylation of methyltransferase in isolated adipocytes. J. Biol. Chem. 262: 15285-15290.
36. Saltiel AR. (1987) Insulin generates an enzyme modulator from hepatic plasma membranes: regulation of adenosine 3′,5′-monophosphate phosphodiesterase, pyruvate dehydrogenase, and adenylate cyclase. Endocrinology 120: 967-972.
37. Saltiel AR, Sorbara-Cazan LR. (1987) Inositol glycan mimics the action of insulin on glucose utilization in rat adipocytes. Biochem. Biophys. Res. Commun. 149: 1084-1092.
38. i and activation of a phospholipase C. Biochemistry 29: 8735-8740.
39. Gaulton GN. (1991) Differential regulation of glycosylated phosphatidylinositol subtypes by insulin. Diabetes 40: 1297-1304.
40. Suzuki S, Sugawara K, Satoh Y, Toyota T. (1991) Insulin stimulates the generation of two putative insulin mediators, inositol-glycan and diacylglycerol in BC3H-1 myocytes. J. Biol. Chem. 266: 8115-8121.
41. Misek DE, Saltiel AR. (1992) An inositol phosphate glycan derived from a Trypanosoma brucei glycosyl-phosphatidylinositol mimics some of the metabolic actions of insulin. J. Biol. Chem. 267: 16266-16273.
42. Deeg MA, Brass EP, Rosenberry TL. (1993) Inositol glycan phosphate derived from human erythrocyte acetylcholinesterase glycolipid anchor and inositol cyclic 1,2-phosphate antagonize glucagon activation of glycogen phosphorylase. Diabetes 42: 1318-1323.
43. Farese RV, Standaert ML, Yamada K, Huang LC, Zhang C, Cooper DR, Wang Z, Yang Y, Suzuki S, Toyota T, Larner J. (1994) Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is detective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats. Proc. Natl. Acad. Sci. U.S.A. 91: 11040-11044.
44. Gaulton GN, Pratt JC. (1994) Glycosylated phosphatidylinositol molecules as second messengers. Semin. Immunol. 6: 97-104.
45. Farese RV. (1990) Lipid-derived mediators in insulin action. Proc. Soc. Exp. Biol. Med. 195: 312-324.
46. Romero GL, Luttrell L, Rogol A, Zeller K, Hewlett E, Larner J. (1988) Phosphatidylinositol-glycan anchors of membrane proteins: Potential precursors of insulin mediators. Science 240: 509-511.
47. Movahedi S, Hooper NM. (1997) Insulin stimulates the release of the glycosyl phosphatidylinositol-anchored membrane dipeptidase from 3T3-L1 adipocytes through the action of a phospholipase C. Biochem. J. 326: 531-537.
48. Larner J. (1987) Banting Lecture: Insulin signaling mechanisms. Lessons from the old testament of glycogen metabolism and the new testament of molecular biology. Diabetes 37: 262-275.
49. Mato JM. (1989) Insulin mediators revisited. Cell. Signal. 1: 143-146.
50. Saltiel AR, Osterman DG, Darnell JC, Sorbara-Cazan LR, Chan BL, Low MG, Cuatrecasas P. (1988) The function of glycosyl phosphoinositides in hormone action. Phil. Trans. R. Soc. Lond. B320: 345-358.
51. Su B, Waneck GL, Flavell RA, Bothwell ALM. (1991) The glycosyl phosphatidylinosilol anchor is critical for Ly-6A/E mediated T cell activation. J. Cell Biol. 112: 377-384.
52. fyn protein tyrosine kinase in T cells. J. Biol. Chem. 267: 12317-12322.
53. Anderson RGW. (1993) Caveolae: where incoming and outgoing messengers meet. Proc. Natl. Acad. Sci. U.S.A. 90: 10909-10913.
54. Anderson RGW. (1993) Plasmalemmal caveolae and GPI-anchored membrane proteins. Curr. Opin. Cell Biol. 5: 647-652.
55. Rothberg KG, Henser JE, Donzell WC, Ying Y-S, Glenney JR, Anderson RGW. (1992) Caveolin, a protein component of caveolae membrane coats. Cell 68: 673-682.
56. Kurzchalia TV, Dupree P, Monier S. (1994) VIP21-Caveolin, a protein of the trans-golgi network and caveolae. FEBS Lett. 346: 88-91.
57. Ying Y-S, Anderson RGW, Rothberg KG. (1992) Each caveolae contains multiple glycosyl-phosphatidylinositol-anchored membrane proteins. Cold Spring Harbor Quant. Biol. 57: 593-604.
58. Lisanti MP, Scherer PE, Tang ZL, Sargiacomo M. (1994) Caveolae, caveolin and caveolin-rich membrane domains: A signaling hypothesis. Trends Cell Biol. 4: 231-235.
59. Bickel PE, Scherer PE, Schnitzer JE, Oh P, Lisanti MP, Lodish HF. (1997) Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins. J. Biol. Chem. 272: 13793-13802.
60. Parton RG. (1996) Caveolae and caveolins. Curr. Opin. Cell Biol. 8: 542-548.
61. Rodgers W, Crise B, Rose JK. (1994) Signals determining protein tyrosine kinase and glycosylphosphatidylinositol-anchored protein targeting to a glycolipid-enriched membrane fraction. Mol. Cell. Biol. 14: 5384-5391.
62. Robbins SM, Quintrell NA, Bishop JM. (1995) Myristoylation and differential palmitoylation of the HCK protein-tyrosine kinases govern their attachment to membranes and association with caveolae. Mol. Cell. Biol. 15: 3507-3515.
63. Stefanova IV, Horejsi V, Ansotegui IJ, Knapp W, Stockinger H. (1991) GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 254: 1016-1019.
64. Shenoy-Scaria AM, Dietzen DJ, Kwong J, Link DC, Lublin DM. (1994) Cysteine of Src family protein tyrosine kinases determines palmitoylation and localization in caveolae. J. Cell Biol. 126: 353-363.
65. Brown DA. (1993) The tyrosine kinase connection: how GPI-anchored proteins activate T cells. Curr. Opin. Immunol. 5: 349-354.
66. Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS, Lisanti MP. (1996) Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. J. Biol. Chem. 271: 15160-15165.
67. Scherer PE, Lisanti MP, Baldini G, Sargiacomo M, Mastick CC, Lodish HF. (1994) Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles. J. Cell Biol. 127: 1233-1243.
68. Parpal S, Gustavsson J, Stralfors S. (1995) Isolation of phosphooligosaccharide/phosphoinositol glycan from caveolae and cytosol of insulin-stimulated cells. J. Cell Biol. 131: 125-135.
69. Gustavsson J, Parpal S, Stralfors P. (1996) Insulin-stimulated glucose uptake involves the transition of glucose transporters to a caveolae-rich fraction within the plasma membrane. Mol. Med. 2: 367-372.
70. Kandror KV, Stephens JM, Pilch PF. (1995) Expression and compartmentalization of caveolin in adipose cells: Coordinate regulation with and structural segregation from GLUT4. J. Cell Biol. 129: 999-1006.
71. Munoz P, Mora S, Sevilla L, Kaliman P, Tomas E, Guma A, Testar X, Palacin M, Zorzano A. (1996) Expression and insulin-regulated distribution of caveolin in skeletal muscle. J. Biol. Chem. 271: 8133-8139.
72. Mastick CC, Brady MJ, Saltiel AR. (1995) Insulin stimulates the tyrosine phosphorylation of caveolin. J. Cell Biol. 129: 1523-1531.
73. Müller G, Wied S. (1993) The sulfonylurea drug, glimepiride, stimulates glucose transport, glucose transporter translocation, and dephosphorylation in insulin resistant rat adipocytes in vitro. Diabetes 42: 1852-1867.
74. Müller G, Ertl J, Gerl M, Preibisch G. (1997) Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J. Biol. Chem. 272: 10585-10593.
75. Müller G, Wied S, Wetekam E-M, Crecelius A, Unkelbach A, Pünter J. (1994) Stimulation of glucose utilization in 3T3 adipocytes and rat diaphragm in vitro by the sulfonylureas, glimepiride and glibenclamide, is correlated with modulations of the cAMP regulatory cascade. Biochem. Pharmacol. 58: 985-996.
76. Müller G, Jordan H, Petry S, Wetekam E-M, Schindler P. (1997) Analysis of lipid metabolism in adipocytes using a fluorescent fatty acid derivative. I. Insulin stimulation of lipogenesis. Biochim. Biophys. Acta 1347: 23-39.
77. Brown DA, Rose JK. (1992) Sorting of GP1-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68: 533-544.
78. Sargiacomo M, Sudol M, Tang Z-L, Lisanti MP. (1993) Signal transducing molecules and glycosylphosphatidylinositol-linked proteins from a caveolin-rich insoluble complex in MDCK cells. J. Cell Biol. 122: 789-807.
79. Müller G, Zimmermann R. (1987) Import of honeybee prepromelittin into the endoplasmic reticulum: structural basis for independence of SRP and docking protein. EMBO J. 6: 2099-2107.
80. Kessler A, Müller G, Wied S, Crecelius A, Eckel J. (1998) Signalling pathways of an insulin-mimetic phosphoinositolglycan-peptide in muscle and adipose tissue. Biochem. J. 330: 277-286.
81. Vlahos CJ, Matter WF, Hui KY, Brown RF. (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269: 5241-5248.
82. Kuo CJ, Chung J, Fiorentino DF, Flanagan WM, Blenis J, Crabree GR. (1992) Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature 358: 70-73.
83. Lazar DF, Wiese RJ, Brady MJ, Mastick CC, Waters SB, Yamauchi K, Pessin JE, Cuatrecasas P, Saltiel AR. (1995) Mitogen-activated protein kinase inhibition does not block the stimulation of glucose utilization by insulin. J. Biol. Chem. 270: 20801-20807.
84. Marte BM, Downward J. (1997) PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem. Sci. 22: 355-358.
85. Sekar N, Li J, Shechter Y. (1996) Vanadium salts as insulin substitutes: mechanism of action, scientific and therapeutic tool in diabetes mellitus research. Crit. Rev. Biochem. Mol. Biol. 31: 339-359.
86. Tsiani E, Fantus IG. (1997) Vanadium compounds. Biological actions and potential as pharmacological agents. Trends Endocrinol. Metab. 8: 51-58.
87. Müller G, Satoh Y, Geisen K. (1995) Extrapancreatic effects of sulfonylureas - a comparison between glimepiride and conventional sulfonylureas. Diabetes Res. Clin. Pract. 28: S115-S137.
88. Müller G, Geisen K. (1996) Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at adipocytes. Horm. Metab. Res. 28: 469-487.
89. Macaulay SL, Larkins RG. (1990) Phospholipase C mimics insulin action on pyruvate dehydrogenase and insulin mediator generation but not glucose transport or utilization. Cell. Signal. 2: 9-19.
90. Tachado SD, Schofield L. (1994) Glycosylphosphatidylinositol toxin of Trypanosoma brucei regulates IL-1α and TNF-α expression in macrophages by protein tyrosine kinase mediated signal transduction. Biochem. Biophys. Res. Commun. 205: 984-991.
91. Argetsinger LS, Hsu GW, Myers MG, Billestrup N, White MF, Carter-Su C. (1995) Growth hormone, interferon-γ, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. J. Biol. Chem. 270: 14685-14692.
92. Johnston JA, Wang L-M, Hanson EP, Sun X-J, White MF, Oakes SA, Pierce JH, O'Shea JJ. (1995) Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. J. Biol. Chem. 270: 28527-28530.
93. Saad MJA, Velloso LA, Carvalho CRO. (1995) Angiotensin II induces tyrosine phosphorylation of insulin receptor substrate I and its association with phosphatidylinositol 3-kinase in rat heart. Biochem. J. 310: 741-744.
94. Uddin S, Yenush L, Sun X-J, Sweet ME, White MF, Platanias LC. (1995) Interferon-α engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3′-kinase. J. Biol. Chem. 270: 15938-15941.
95. Kowalski-Chauvel A, Pradayrol L, Vaysse N, Seva C. (1996) Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase. J. Biol. Chem. 271: 26356-26361.
96. Velloso IA, Folli F, Sun XJ, White MF, Saad MJA, Kahn CR. (1996) Cross-talk between the insulin and angiotensin signaling systems. Proc. Natl. Acad. Sci. U.S.A. 93: 12490-12495.
97. Flier JS. (1993) An overview of insulin resistance. In: Moller DE (ed). Insulin Resistance. John Wiley & Sons, New York, pp. 1-7.